Showing results (291-300 of 16,798) with videos related to

Sort By:
Pageof 1,680
British Journal of Haematology|February 23, 2019
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studiesDavid J Kuter, Adrian Newland, Beng H Chong, et al.
British Journal of Haematology|February 23, 2019
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general populationLaura Magnano, Sara Alonso-Alvarez, Miguel Alcoceba, et al.
British Journal of Haematology|February 22, 2019
Expression of GNAZ, encoding the Gαz protein, predicts survival in mantle cell lymphomaFilip Mundt, Magali Merrien, Lina Nygren, et al.
British Journal of Haematology|November 22, 2018
Aplastic anaemia in pregnancy - a single centre, North American seriesKelly E McGowan, Ann K Malinowski, Andre C Schuh, et al.
British Journal of Haematology|November 22, 2018
Current considerations in AYA Hodgkin lymphomaJennifer L Crombie, Ann S LaCasce
British Journal of Haematology|November 22, 2018
Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell diseaseAshley Thrower, Emily J Ciccone, Poulami Maitra, et al.
British Journal of Haematology|March 8, 2019
Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED studyClara M A de Bruijn, Frédéric Millot, Meinolf Suttorp, et al.
British Journal of Haematology|February 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphomaJohanna Veldman, Zainab N D Alsada, Anke van den Berg, et al.
British Journal of Haematology|February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN studyStephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
British Journal of Haematology|March 1, 1988
Transient platelet and HLA antibody formation in multitransfused patients with malignancyK McGrath, M Wolf, J Bishop, et al.
Pageof 1,680